Head-to-head for women
CoreAge Rx vs Invyncible
CoreAge Rx and Invyncible both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
CoreAge Rx
Higher scoreRanked #1 for women · Grade A−
Metabolic-Fit / 100
Best for: Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
Visit CoreAge RxInvyncible
Ranked #80 for women · Grade C
Metabolic-Fit / 100
Best for: A mother who wants the option to start compounded and later move to an FDA-approved brand pen without switching providers, and who values knowing the company's actual name and address.
Visit InvyncibleThe verdict for women
CoreAge Rx edges out Invyncible on the Metabolic-Fit Score, 92 to 45 (A− vs C). Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
Invyncible is still a genuine option — one of the few programs on this list selling both compounded semaglutide/tirzepatide (from $192.50/$210 a month) and the FDA-approved brand pens (Wegovy, Zepbound) itself — plus real transparency about who runs it — but it doesn't publish a state list, so you won't know if it reaches you until you start the intake. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Invyncible |
|---|---|---|
| Metabolic-Fit Score | 92/100 · A− | 45/100 · C |
| Overall rank | #1 | #80 |
| Semaglutide | $99/mo | $192.50/mo |
| Tirzepatide | $149/mo | $210/mo |
| Coverage | All 50 states | Not publicly disclosed; confirmed during intake |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Metabolic-Fit / 100
CoreAge Rx
Ranked #1 · Grade A−
What we like
- A single flat monthly rate — no teaser first month that jumps at the first refill
- A prescriber reviews your history and will actually talk through timing if you're postpartum, nursing, or planning another pregnancy
- Semaglutide and tirzepatide on one chart, so switching molecules doesn't mean switching providers
The caveats
- Not the lowest sticker price — a couple of budget compounders come in under it
- Compounded only; there's no FDA-approved brand Wegovy or Zepbound lane here
- A general metabolic program, not a dedicated OB or hormone practice
Metabolic-Fit / 100
Invyncible
Ranked #80 · Grade C
What we like
- Discloses its corporate parent and a physical address — real accountability, not just a trade name
- LegitScript-verified
- Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on one account
The caveats
- No state-availability list published — you find out if it reaches you during intake
- Every price is shown as a permanent 'sale' against a higher reference price, which reads like a discount but never actually changes
- Brand-name Wegovy/Zepbound pricing ($1,540–$1,750/mo) is still well above most insurance-backed options
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Invyncible against other providers we review for women.
Or browse the full comparison hub.